Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis
about
Tyro3 family-mediated cell entry of Ebola and Marburg virusesAXL kinase as a novel target for cancer therapyProstate cancer and parasitism of the bone hematopoietic stem cell nicheThe Gas6/TAM System and Multiple SclerosisTargeting the TAM Receptors in LeukemiaRole of Gas6 in erythropoiesis and anemia in miceSelective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma.GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy.Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.Axl as a mediator of cellular growth and survivalGAS6 receptor status is associated with dormancy and bone metastatic tumor formationTAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets.Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target.The prostate cancer bone marrow niche: more than just 'fertile soil'.Axl-dependent signalling: a clinical update.TAM receptors in leukemia: expression, signaling, and therapeutic implications.TAM receptors and the regulation of erythropoiesis in miceHeightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.Critical signal transduction pathways in CLL.Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+CD25+ Regulatory T Cells Mainly through Axl ReceptorAutocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6.Giving AXL the axe: targeting AXL in human malignancy.AXL receptor tyrosine kinase as a therapeutic target in NSCLC.Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies.Essential role of Gas6 for glomerular injury in nephrotoxic nephritis.Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody.Function of Axl receptor tyrosine kinase in non-small cell lung cancer.Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
P2860
Q24670567-DF770D0E-3898-45F3-A7DA-223B29A83A23Q26863442-D91990A2-B83D-480C-9CA9-AC791ECB95F3Q26996231-B686B0C3-72F9-42E7-9607-4745D2E5A2D0Q28067131-426EE7DC-FCCD-4672-BFB5-1E7E5D48F2ACQ28078654-72BB327E-F5DE-4B4D-8A6E-D7BE16CCBDD2Q28513935-E29DADD8-2B05-414B-959B-8A00C8543546Q33442949-277BE575-271F-4226-9023-251CE4BC052EQ33591281-C473024B-F81B-4400-9D99-A726F9BB0130Q33622570-E19DDADD-4EB0-4086-B0E7-A2F95F5DCA8DQ33765614-4788D946-C9FF-4662-B95B-0834DC455397Q33806028-DF9FC7CA-8E11-4DD9-B83F-80887C90A7A7Q34619118-E151FDD6-E2C9-483C-9724-EA233C9DEE51Q34700694-EAA43FB6-4D54-4556-81A6-2F879EF0FF7BQ34794927-BF2F9147-2283-41CF-A871-3720ED4280C1Q35125173-E726F34C-84B8-40E1-87F4-65F4D2666F63Q35631557-7222644D-0DDF-4D3A-80D0-177E3D2953A9Q35786887-60F1A669-D59E-4409-B8D5-1DD994B6240CQ35872635-79426CA1-F7F0-403B-80AE-F85AF4F01E9CQ36682854-B78FAB42-49FB-4E95-A8B3-09E99C04C32DQ36700788-0E0E72AC-41E3-42CF-923A-32A159F011E0Q36720080-FFF7E88E-7642-4E5A-BE0D-3C2F93534E7CQ36865209-D35EB3F0-7E47-42D2-8CFF-3B39EA59BA52Q37112879-C054FBDE-4634-4DD9-A972-48BD102804E9Q37541225-096A6984-7F51-473C-B752-0849E7CB7AE5Q37571068-ABE6519E-A8E9-4A70-ABC5-CD5CBAEEEECDQ37657343-8AA25E2E-A18D-49B7-8C6C-2FAC2AD065A9Q38718211-1786E9D6-7F1F-4BB2-8D3B-C28119FA19F4Q38772267-2CB628D7-E082-488E-BAE7-B6141E2EFE16Q39139917-4547F8C9-E455-4326-9E74-B11F96FC2047Q39157476-208A2205-9255-4C27-86A9-310289CB9D9DQ39738129-6B49D3ED-6CE4-44A4-A385-CCA338F0B138Q41677325-CAD33990-427B-41CC-85E1-2702A16C3AF7Q41838847-DC039A98-6C98-40EE-8D60-0A0C9275D9CAQ49636410-C6573260-546C-43DC-B694-92474C02EEA2Q57066901-7EC14344-42BC-4B68-B9D2-0511498A22A0
P2860
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Expression of axl, a transform ...... al and malignant hematopoiesis
@ast
Expression of axl, a transform ...... al and malignant hematopoiesis
@en
Expression of axl, a transform ...... al and malignant hematopoiesis
@nl
type
label
Expression of axl, a transform ...... al and malignant hematopoiesis
@ast
Expression of axl, a transform ...... al and malignant hematopoiesis
@en
Expression of axl, a transform ...... al and malignant hematopoiesis
@nl
prefLabel
Expression of axl, a transform ...... al and malignant hematopoiesis
@ast
Expression of axl, a transform ...... al and malignant hematopoiesis
@en
Expression of axl, a transform ...... al and malignant hematopoiesis
@nl
P2093
P1433
P1476
Expression of axl, a transform ...... al and malignant hematopoiesis
@en
P2093
Fiebeler A
Neubauer A
O'Bryan JP
Schmidt CA
Snodgrass HR
P304
P407
P577
1994-09-01T00:00:00Z